title: [Cardiovascular risks differences in women: how can we improve the management?].
abstract: Some aspects of cardiovascular risk differ in women; on the whole, this risk is underestimated and insufficiently treated because of lack of knowledge of the problem. According to an INSERM report in 1999, one Frenchwoman in three will die from a cardiovascular disease, while only one in 25 will die of breast cancer. For new generations of women, the protective effect of the estrogen burden may be counterbalanced by the increasing prevalence during the perimenopausal period of metabolic syndrome, particularly harmful in terms of cardiovascular risk. Before oral contraceptives are prescribed, an extremely thorough history must be taken. These should in no case be prescribed for smokers older than 35 years, regardless of how little they smoke. Neither uncomplicated diabetes nor controlled dyslipidemia is a contraindication to hormonal contraception for women. It now seems clear that hormone therapy of menopause does not prevent cardiovascular disease. Nor, however, does it increase the risk if it is administered early, that is, during the first five years of menopause, and accompanied by close monitoring of cardiovascular risk factors and annual reassessment of the benefit-risk balance. The old cliché remains true: the patient at high risk of cardiovascular disease is a man older than 50 years, who smokes and is obese. But men still die more often from cancer than from cardiovascular disease, while the latter is the leading of cause in women, especially after menopause. The symptoms are often misleading and diagnosis is thus frequently delayed. Smoking, lack of exercise, overweight, and stress are all risk factors in women of all ages, and exposure to them can increase as women grow older. These factors should alert the physician and induce earlier screening for cardiovascular disease. In practice, too many women and their physicians underestimate their real risk of cardiovascular accident. It is accordingly essential to develop new campaigns of information and prevention specifically for women.
authors.affiliation: Service de médecine vasculaire et HTA, Pôle de cardiologie et des maladies vasculaires, Université de Lille 2 - Faculté de médecine Henri Warembourg, CHRU, F-59037 Lille Cedex, France. clairemouniervehier@orange.fr
authors.forename: Claire
authors.initials: C
authors.lastname: Mounier-Vehier
authors.forename: Pascal
authors.initials: P
authors.lastname: Delsart
authors.forename: Brigitte
authors.initials: B
authors.lastname: Letombe
mesh_terms: D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D002423:Cause of Death; D015914:Estrogen Replacement Therapy; D005260:Female; D005602:France / Q000453:epidemiology; D006293:Health Promotion; D006801:Humans; D008403:Mass Screening; D024821:Metabolic Syndrome / Q000150:complications; D050177:Overweight / Q000150:complications; D015995:Prevalence; D018570:Risk Assessment; D012307:Risk Factors; D012727:Sex Characteristics; D017678:Sex Distribution; D012907:Smoking / Q000009:adverse effects; D013315:Stress, Psychological / Q000150:complications; D016387:Women's Health